Dan G Duda

46PUBLICATIONS
226CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsTumour immunologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Dec 08, 2025
Inhibiting B cells enhances the efficacy of STING agonism or immune checkpoint blockade in hepatocellular carcinoma.

Xin Liu, Zelong Liu, Chengzhan Zhu

|May 05, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Xin Liu, Zelong Liu, Tatsuya Kobayashi

|Mar 17, 2025
Inhibiting B-cell-mediated Immunosuppression to Enhance the Immunotherapy Efficacy in Hepatocellular Carcinoma.

Xin Liu, Zelong Liu, Tatsuya Kobayashi

|Jan 22, 2025
Targeting EPHB2/ABL1 restores antitumor immunity in preclinical models of ependymoma.

Jun Ren, Zohreh Amoozgar, Taylor P Uccello

|Nov 08, 2024
Fluorescence Lifetime Imaging Enables In Vivo Quantification of PD-L1 Expression and Intertumoral Heterogeneity.

Rahul Pal, Murali Krishnamoorthy, Aya Matsui

|Nov 08, 2024
Combination CXCR4 and PD-1 Blockade Enhances Intratumoral Dendritic Cell Activation and Immune Responses Against Hepatocellular Carcinoma.

Satoru Morita, Pin-Ji Lei, Kohei Shigeta

Pageof 8

Frequent Collaborators

14 joint publications

Rakesh K Jain

7 joint publications

Dai Fukumura

5 joint publications

Xin Liu

4 joint publications

Pin-Ji Lei